Clinical Trials in Chicago

Showing 18381-18400 of 20,493 trials

Combined Social Worker and Pharmacist Transitional Care Program

NCT01503554

In an effort to improve care coordination and reduce hospital readmissions, Rush University Medical Center developed the Combined Social Worker and Pharmacist Program, which targets both the psychosocial and clinical risk factors that can lead to rehospitalization. This study will evaluate the impact of this program on 30-day same hospital readmission rates and total cost of care.

Patient AdmissionPatient Discharge

Rush University Medical Center100 participantsStarted Apr 2011

Chicago, Illinois, United States

COMPLETEDPhase 22.2 miles

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

NCT00006345

RATIONALE: Denileukin diftitox may be able to deliver cancer-killing substances directly to T-cell lymphoma cells. Dexamethasone may decrease the side effects of denileukin diftitox. PURPOSE: Phase II trial to study the effectiveness of dexamethasone in preventing side effects following treatment with denileukin diftitox in treating patients who have persistent or recurrent T-cell lymphoma.

Drug/Agent Toxicity by Tissue/OrganLymphoma

Ligand PharmaceuticalsStarted Nov 1999

Miami, Florida, United States • Chicago, Illinois, United States • New Orleans, Louisiana, United States +8 more locations

Combined Social Worker and Pharmacist Transitional Care Program

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

Find Trials by Condition in Chicago

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia

Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Quality of Life in Survivors of Gynecologic Cancer

Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

Fecal Biomarker Study for Patients With Ulcerative Colitis

Irofulven in Treating Patients With Stage IV Melanoma

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors

Stress Management Training in Patients Undergoing Radiation Therapy for Cancer

Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain

A Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunteers With Varying Degrees of Kidney Function

Clinical Efficacy Study Comparing VisionScope Imaging (VSI) to Magnetic Resonance Imaging (MRI) in Injuries of the Knee